Review





Similar Products

cd40 pe vio 770 clone rea965  (Miltenyi Biotec)
93
Miltenyi Biotec cd40 pe vio 770 clone rea965
Cd40 Pe Vio 770 Clone Rea965, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd40 pe vio 770 clone rea965/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
cd40 pe vio 770 clone rea965 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cd40 pe  (Miltenyi Biotec)
95
Miltenyi Biotec cd40 pe
SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression <t>(CD40,</t> CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)
Cd40 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd40 pe/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd40 pe - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
pe-conjugated anti-mouse cd40 ebiosciencetm 12-0401-81  (Thermo Fisher)
90
Thermo Fisher pe-conjugated anti-mouse cd40 ebiosciencetm 12-0401-81
SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression <t>(CD40,</t> CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)
Pe Conjugated Anti Mouse Cd40 Ebiosciencetm 12 0401 81, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-conjugated anti-mouse cd40 ebiosciencetm 12-0401-81/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
pe-conjugated anti-mouse cd40 ebiosciencetm 12-0401-81 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-human cd154 (cd40 ligand) pe-cyanine5 clone 24-31  (Thermo Fisher)
90
Thermo Fisher anti-human cd154 (cd40 ligand) pe-cyanine5 clone 24-31
SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression <t>(CD40,</t> CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)
Anti Human Cd154 (Cd40 Ligand) Pe Cyanine5 Clone 24 31, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human cd154 (cd40 ligand) pe-cyanine5 clone 24-31/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-human cd154 (cd40 ligand) pe-cyanine5 clone 24-31 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pe-conjugated anti-mouse cd40 12-04-1082  (Thermo Fisher)
90
Thermo Fisher pe-conjugated anti-mouse cd40 12-04-1082
SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression <t>(CD40,</t> CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)
Pe Conjugated Anti Mouse Cd40 12 04 1082, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-conjugated anti-mouse cd40 12-04-1082/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
pe-conjugated anti-mouse cd40 12-04-1082 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti cd40 pe  (Miltenyi Biotec)
97
Miltenyi Biotec anti cd40 pe
SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression <t>(CD40,</t> CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)
Anti Cd40 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd40 pe/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
anti cd40 pe - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
anti cd40 phycoerythrin pe  (Proteintech)
93
Proteintech anti cd40 phycoerythrin pe
SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression <t>(CD40,</t> CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)
Anti Cd40 Phycoerythrin Pe, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd40 phycoerythrin pe/product/Proteintech
Average 93 stars, based on 1 article reviews
anti cd40 phycoerythrin pe - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
pe-cd40 antibody  (Thermo Fisher)
90
Thermo Fisher pe-cd40 antibody
Effects of Epimedium flavonoids on the maturation of RAW 264.7 cells. Cell was assessed 24 h after compounds treatment in RAW 264.7 cells. The experiment was repeated three times for consistency. (A–C) . Effects of Epimedium flavonoids on the expression of <t>CD40,</t> CD80, and CD86, and (D, E) effects on MHC-I and MHC-II in RAW 264.7 cells, as detected by flow cytometry. RAW264.7 cells were gated on size and complexity using a two-dimensional FSC vs. SSC plot, then assessed for MHC-I, MHC-II, CD40, CD80 and CD86. Statistical analyses were performed using one-way ANOVA, followed by Tukey’s multiple comparisons test to adjust for multiple comparisons. All data are expressed as mean ± SD (n = 3). Statistical significance is indicated as follows: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with the control group.
Pe Cd40 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-cd40 antibody/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
pe-cd40 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression (CD40, CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)

Journal: Journal of Neuroinflammation

Article Title: Microglial clearance, neuroprotection and cognitive recovery via a novel synthetic sulfolipid in Alzheimer’s disease

doi: 10.1186/s12974-025-03634-w

Figure Lengend Snippet: SULF A-dependent modulation of microglial activation and arginine metabolism. ( A ) RT-PCR analysis of cytokine and microglial marker gene expression following 24 h treatment. ( B ) CCL2 secretion quantified by ELISA at 48 h (n = 12). ( C ) Flow cytometric analysis of surface marker expression (CD40, CD86, MHC II, CD200R, TREM2) on untreated microglia (CTRL) or cells treated with 10 µg/mL SULF A for 24 h, expressed as mean fluorescence intensity (MFI; n = 6). ( D ) Schematic of iNOS/ARG metabolic pathways. ( E ) Quantification of nitric oxide (NO) release in culture supernatants by Griess assay at 48 h (n = 12). ( F ) Frequency of microglial cells expressing ARG, iNOS, or both, after 48 h of SULF A treatment (n = 6); ( G–H ) Representative FACS plots showing ARG⁺, iNOS⁺, and ARG⁺iNOS⁺ populations in untreated and SULF A-treated microglia. Data represent mean ± SEM. Statistical significance determined by paired t-test (P < 0.05; **P < 0.001; ***P < 0.0001)

Article Snippet: Surface markers were assessed by staining with anti-mouse CD11b-VioBlue, CD40-PE, CD86-FITC, CD200R-APC (Miltenyi Biotec), and TREM2-APC (R&D Systems) according to standard protocols.

Techniques: Activation Assay, Reverse Transcription Polymerase Chain Reaction, Marker, Gene Expression, Enzyme-linked Immunosorbent Assay, Expressing, Fluorescence, Griess Assay

Effects of Epimedium flavonoids on the maturation of RAW 264.7 cells. Cell was assessed 24 h after compounds treatment in RAW 264.7 cells. The experiment was repeated three times for consistency. (A–C) . Effects of Epimedium flavonoids on the expression of CD40, CD80, and CD86, and (D, E) effects on MHC-I and MHC-II in RAW 264.7 cells, as detected by flow cytometry. RAW264.7 cells were gated on size and complexity using a two-dimensional FSC vs. SSC plot, then assessed for MHC-I, MHC-II, CD40, CD80 and CD86. Statistical analyses were performed using one-way ANOVA, followed by Tukey’s multiple comparisons test to adjust for multiple comparisons. All data are expressed as mean ± SD (n = 3). Statistical significance is indicated as follows: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with the control group.

Journal: Frontiers in Pharmacology

Article Title: The immunostimulatory activity of Epimedium flavonoids involves toll-like receptor 7/8

doi: 10.3389/fphar.2025.1514284

Figure Lengend Snippet: Effects of Epimedium flavonoids on the maturation of RAW 264.7 cells. Cell was assessed 24 h after compounds treatment in RAW 264.7 cells. The experiment was repeated three times for consistency. (A–C) . Effects of Epimedium flavonoids on the expression of CD40, CD80, and CD86, and (D, E) effects on MHC-I and MHC-II in RAW 264.7 cells, as detected by flow cytometry. RAW264.7 cells were gated on size and complexity using a two-dimensional FSC vs. SSC plot, then assessed for MHC-I, MHC-II, CD40, CD80 and CD86. Statistical analyses were performed using one-way ANOVA, followed by Tukey’s multiple comparisons test to adjust for multiple comparisons. All data are expressed as mean ± SD (n = 3). Statistical significance is indicated as follows: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with the control group.

Article Snippet: Fluorophore-conjugated antibodies, including PE-CD40, PE-CD80, PE-CD86, PE-MHC-I, PE-MHC-II and PE-CD11c were acquired from Thermo Fisher Scientific (Waltham, MA, United States) and eBioscience (San Diego, CA, United States), IL-4 and IFN-γ enzyme-linked immunosorbent assay (ELISA) were obtained from Universal Biotech Co., Ltd (Shanghai, China).

Techniques: Expressing, Flow Cytometry, Control

Effects of icaritin, icariin I and icariin II on the maturation of BMDCs. Cell was assessed 24 h after compounds treatment in BMDCs. The experiment was repeated three times for consistency. (A–C) Effects of Epimedium flavonoids on the expression of CD40, CD80, and CD86, and (D, E) effects on MHC-I and MHC-II in BMDCs, as assessed by flow cytometry. BMDCs cells were selected using a two-dimensional FSC vs. SSC plot, followed by gating on CD11c for DCs. Then assessed for MHC-I, MHC-II, CD40, CD80 and CD86. Statistical analyses were performed using one-way ANOVA, followed by Tukey’s multiple comparisons test to adjust for multiple comparisons. All data are presented as mean ± SD (n = 3). Statistical significance is indicated as follows: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with the control group.

Journal: Frontiers in Pharmacology

Article Title: The immunostimulatory activity of Epimedium flavonoids involves toll-like receptor 7/8

doi: 10.3389/fphar.2025.1514284

Figure Lengend Snippet: Effects of icaritin, icariin I and icariin II on the maturation of BMDCs. Cell was assessed 24 h after compounds treatment in BMDCs. The experiment was repeated three times for consistency. (A–C) Effects of Epimedium flavonoids on the expression of CD40, CD80, and CD86, and (D, E) effects on MHC-I and MHC-II in BMDCs, as assessed by flow cytometry. BMDCs cells were selected using a two-dimensional FSC vs. SSC plot, followed by gating on CD11c for DCs. Then assessed for MHC-I, MHC-II, CD40, CD80 and CD86. Statistical analyses were performed using one-way ANOVA, followed by Tukey’s multiple comparisons test to adjust for multiple comparisons. All data are presented as mean ± SD (n = 3). Statistical significance is indicated as follows: **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with the control group.

Article Snippet: Fluorophore-conjugated antibodies, including PE-CD40, PE-CD80, PE-CD86, PE-MHC-I, PE-MHC-II and PE-CD11c were acquired from Thermo Fisher Scientific (Waltham, MA, United States) and eBioscience (San Diego, CA, United States), IL-4 and IFN-γ enzyme-linked immunosorbent assay (ELISA) were obtained from Universal Biotech Co., Ltd (Shanghai, China).

Techniques: Expressing, Flow Cytometry, Control